Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients

Catheterization and Cardiovascular Interventions

Volumn 53, Issue 3, 2001, Pages 341-345

  Madyoon, Hooman ^a   Croushore, Linda ^a   Weaver, Douglas ^b   Mathur, Vandana ^c  

^a St Joseph's Medical Center Stockton   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute renal failure; Angiography; Contrast; Dopamine agonist; Kidney

Indexed keywords

CONTRAST MEDIUM; FENOLDOPAM; FENOLDOPAM MESILATE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; INCIDENCE; KIDNEY DISEASE;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY; CONTRAST MEDIA; CREATININE; FEMALE; FENOLDOPAM; HUMANS; KIDNEY FAILURE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VASODILATOR AGENTS;

EID: 0034932912     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.1178     Document Type: Article

References (28)

1. Contrast-medium-induced acute renal failure
2. Contrast induced nephrotoxicity in patients undergoing cardiac catheterization
3. Nephrotoxicity of contrast media
4. Contrast medium-associated nephropathy. Recognition and management
5. The effect of acute renal failure on mortality: A cohort analysis
6. Acute renal failure requiring hemodialysis after percutaneous coronary intervention: In hospital and one-year outcomes
7. The detrimental impact of chronic renal insufficiency and diabetes mellitus on late prognosis after percutaneous coronary interventions
8. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents
9. Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans
10. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency
11. Effects of intravenous contrast media on cortical and medullary blood flow in the rat kidney
12. Blood flow distribution during controlled hypotension induced by fenoldopam in anesthetized dogs
13. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors
14. Fenoldopam: A dopamine type 1 receptor agonist in the prevention of renal injury associated with the administration of intravascular contrast
15. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus
16. Nephrotoxicity from angiographic contrast material
17. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine
18. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial
19. Renal and hemodynamic effects of intravenous fenoldopam in severe hypertension
20. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function
21. Fenoldopam reverses cyclosporine-induced renal vasoconstriction in kidney transplant recipients
22. Fenoldopam: An effective renal preservation agent in cardiac surgery?
23. Fenoldopam improves acute renal failure and patient outcome in the ICU setting
24. Renal protection and reduced mortality using fenoldopam (a DA-1 agonists) in patients undergoing TAAA repair
25. Renal and systemic effects of very low-dose fenoldopam in normotensive subjects
26. Therapeutics for hypertensive urgencies and emergencies: Fenoldopam, a novel systemic and renal vasodilator
27. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects
28. Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients